Search Results - Dipak Kotecha
- Showing 1 - 11 results of 11
-
1
-
2
Unraveling the relationships between alpha- and beta-adrenergic modulation and the risk of heart failure by Claire Baudier, Françoise Fougerousse, Folkert W. Asselbergs, Folkert W. Asselbergs, Folkert W. Asselbergs, Mickael Guedj, Michel Komajda, Dipak Kotecha, Dipak Kotecha, Dipak Kotecha, R. Thomas Lumbers, R. Thomas Lumbers, R. Thomas Lumbers, Amand F. Schmidt, Amand F. Schmidt, Amand F. Schmidt, Amand F. Schmidt, Amand F. Schmidt, Benoît Tyl
Published in Frontiers in Cardiovascular Medicine (2023-10-01)Get full text
Article -
3
-
4
Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care by Deirdre A. Lane, Flemming Skjøth, Gregory Y. H. Lip, Torben B. Larsen, Dipak Kotecha
Published in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2017-05-01)Get full text
Article -
5
Development of automated neural network prediction for echocardiographic left ventricular ejection fraction by Yuting Zhang, Boyang Liu, Karina V. Bunting, Karina V. Bunting, David Brind, David Brind, David Brind, Alexander Thorley, Andreas Karwath, Andreas Karwath, Wenqi Lu, Diwei Zhou, Xiaoxia Wang, Xiaoxia Wang, Xiaoxia Wang, Alastair R. Mobley, Alastair R. Mobley, Otilia Tica, Georgios V. Gkoutos, Georgios V. Gkoutos, Georgios V. Gkoutos, Dipak Kotecha, Dipak Kotecha, Dipak Kotecha, Jinming Duan
Published in Frontiers in Medicine (2024-04-01)Get full text
Article -
6
-
7
Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease by Ravi Vijapurapu, Derralynn A Hughes, Tarekegn Geberhiwot, Richard Paul Steeds, Dipak Kotecha, Adrian Warfield, James Moon, Peter Woolfson, Polyvios Demetriades, Ashwin Roy, Joseph de Bono
Published in Open Heart (2023-11-01)Get full text
Article -
8
B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease by Dipak Kotecha, Marcus D. Flather, Dan Atar, Peter Collins, John Pepper, Elizabeth Jenkins, Christopher M. Reid, David Eccleston, on behalf of the Alternative Risk Markers in Coronary Artery Disease (ARM-CAD) Study
Published in BMC Medicine (2019-04-01)Get full text
Article -
9
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic eve... by Raffaele De Caterina, Kurt Huber, Richard Schilling, Miklos Rohla, Thomas W Weiss, Ladislav Pecen, Giuseppe Patti, Jolanta M Siller-Matula, Renate B Schnabel, Dipak Kotecha, Markus Lucerna, Paulus Kirchhof
Published in BMJ Open (2019-03-01)Get full text
Article -
10
2016 ESC GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPEDIN COLLABORATION WITH EACTS by Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castella, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks, Gerhard Hindricks, Antonis S. Manolis, Jonas Oldgren, Bogdan Alexandru Popescu, Ulrich Schotten, Bart Van Putte, Panagiotis Vardas
Published in Российский кардиологический журнал (2017-08-01)Get full text
Article -
11
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis. by Ana-Catarina Pinho-Gomes, Luis Azevedo, Emma Copland, Dexter Canoy, Milad Nazarzadeh, Rema Ramakrishnan, Eivind Berge, Johan Sundström, Dipak Kotecha, Mark Woodward, Koon Teo, Barry R Davis, John Chalmers, Carl J Pepine, Kazem Rahimi, Blood Pressure Lowering Treatment Trialists’ Collaboration
Published in PLoS Medicine (2021-06-01)Get full text
Article
